Authentikos Wealth Advisory’s Merck MRK Stock Holding History

Authentikos Wealth Advisory’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-43	Closed	-$4.43K	–	379
2023 Q3	$4.43K	Buy	+43	New	+$4.63K	﹤0.01%	319

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Authentikos Wealth Advisory's MRK Position: Q4 2023 in Review

Authentikos Wealth Advisory sold out of Merck (MRK) in Q4 2023, closing a stake of 43 shares — an estimated $4.43K sold.

Authentikos Wealth Advisory first reported a position in MRK in Q3 2023 and held it in 1 quarter. The position peaked at $4.43K in Q3 2023. 3,434 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

Authentikos Wealth Advisory reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
Authentikos Wealth Advisory sold 43 Merck shares in Q4 2023, an estimated $4.43K.
Authentikos Wealth Advisory first reported a position in Merck in Q3 2023 and held it in 1 quarter.
Authentikos Wealth Advisory's Merck position peaked at $4.43K in Q3 2023.
3,434 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Authentikos Wealth Advisory's 13F filing for Q4 2023, filed 30 Jan 2024.